Intercell, Merck S. Aureus Shot Effective in Renal Disease - Bloomberg PDF Print
Bloomberg
s experimental vaccine against a deadly hospital infection provoked an immune response in a trial of patients with end- stage renal disease. The study, from the second of three phases of human testing generally required for regulatory approval,

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.